Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03447574 · ClinicalTrials.gov registry record · NA
Fluid Volume During Fluid Shifts
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03447574: Completed NA study, sponsored by Mayo Clinic.
NCT03447574 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03447574, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study is designed to answer the question of if several non-invasive methods are comparable to the invasive clinical gold standard of radiolabeled albumin in terms of detecting changes in fluid volume. It is broken into two studies: Aim 1 Study A is designed as a pilot phase to develop the non-techniques, and Aim 2 Study B is comparing these techniques to the gold standard.
Interventions
- OTHER ethanol dilution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-06-27 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03447574
The ClinicalTrials.gov registry entry for NCT03447574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ethanol dilution is the first listed.
NCT03447574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03447574 about?
NCT03447574 is a clinical study titled "Fluid Volume During Fluid Shifts". This study is designed to answer the question of if several non-invasive methods are comparable to the invasive clinical gold standard of radiolabeled albumin in terms of detecting changes in fluid volume. It is broken into two studies: Aim 1 Study A is designed as a pilot phase to develop the non-...
What is the current status of trial NCT03447574?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-06-27. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT03447574?
The interventions under investigation include: ethanol dilution (OTHER).
Who is sponsoring clinical trial NCT03447574?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.